Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
KLARIA PHARMA Aktie jetzt für 0€ handeln | |||||
10.01. | Klaria Pharma Holding AB: Klaria signs license agreement for Sumatriptan Alginate film in Europe with CNX Therapeutics | 86 | GlobeNewswire (Europe) | Klaria Pharma Holding AB (publ) ("Klaria" or the "Company") announces that the Company has signed a license agreement for Sumatriptan Alginate Film (the "Product"), a pharmaceutical product based on... ► Artikel lesen | |
21.11.24 | Klaria Pharma Holding AB: Klaria Interim Report Q3 2024 | 39 | GlobeNewswire (Europe) | Klaria Interim Report Q3 2024
1 July - 30 September 2024
Third quarter of 2024
The group in total
- Net sales 0.0 MSEK (0.6 MSEK)
- Other income 0.0 MSEK (0.0 MSEK)
- R&D expenses for the... ► Artikel lesen | |
22.08.24 | Klaria Pharma Holding AB: Klaria Interim Report Q2 2024 | 36 | GlobeNewswire (Europe) | Summary of Interim Report
First quarter of 2024
The group in total
- Net sales 0.0 MSEK (0.0 MSEK)
- Other income 0.0 MSEK (0.3 MSEK)
- R&D expenses for the quarter amounted to 0.5 MSEK (7.0... ► Artikel lesen |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
BRISTOL-MYERS SQUIBB | 53,59 | +0,21 % | Bristol-Myers' Opdualag fails Phase 3 melanoma study | ||
DERMAPHARM | 38,600 | 0,00 % | Dermapharm: Aktie wird abgestuft | 2024 ist für Dermapharm gut verlaufen. Die Analysten von mwb research gehen davon aus, dass die Gesellschaft ihre Jahresprognose schaffen wird. Dermapharm rechnet mit einem Umsatz von 1,17 Milliarden... ► Artikel lesen | |
SYNBIOTIC | 4,080 | -2,16 % | SYNBIOTIC plant weitere Übernahmen in 2025 | Mitteilung der SYNBIOTIC SE: SYNBIOTIC mit vier neuen Beteiligungen in 2024: Weitere Übernahmen für 2025 in Sicht Die europäische Industriehanf- und Cannabis-Unternehmensgruppe SYNBIOTIC SE (ISIN DE000A3E5A59... ► Artikel lesen | |
INCYTE | 67,00 | +0,12 % | Incyte Q4 Adj. EPS Misses Estimates, Revenues Beat; Sees Revenue Growth In FY25 | WASHINGTON (dpa-AFX) - Pharma company Incyte Corp. (INCY) reported Monday slightly higher earnings in its fourth quarter with strong growth in revenues. Adjusted earnings missed the Wall Street... ► Artikel lesen | |
WPD PHARMACEUTICALS | 0,113 | 0,00 % | CSE Bulletin: Consolidation - WPD Pharmaceuticals Inc. (WBIO) | le 23 décembre/December 2024
WPD Pharmaceuticals Inc. has announced a consolidation of its issued and outstanding common shares on the basis of one (1) post-consolidated common share for every twenty-five... ► Artikel lesen | |
GREEN THUMB INDUSTRIES | 7,080 | +1,87 % | Multi-Bagger entdeckt!: Der europäische Cannabissektor wird in den nächsten Jahren auf 24 Mrd. $ explodieren - diese Aktie profitiert! | ||
INDIVA | 0,016 | 0,00 % | SNDL Inc.: SNDL Emerges as Canada's Leading Producer of Edibles with Indiva Acquisition | CALGARY, AB, Nov. 4, 2024 /CNW/ - SNDL Inc. (Nasdaq: SNDL) ("SNDL" or the "Company") announced today that, in the context of Indiva Limited's ("Indiva" and together... ► Artikel lesen | |
HAPPY BELLY FOOD GROUP | 0,740 | 0,00 % | Happy Belly Food Group Inc.: Happy Belly's Smile Tiger Coffee Roasters Signs 25-Unit Area Development Agreement in British Columbia | Toronto, Ontario--(Newsfile Corp. - February 13, 2025) - Happy Belly Food Group Inc. (CSE: HBFG) (OTCQB: HBFGF) ("Happy Belly" or the "Company"), a leading consolidator of emerging food brands is happy... ► Artikel lesen | |
KHIRON LIFE SCIENCES | 0,029 | 0,00 % | XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 15.08.2024 | The following instruments on Boerse Frankfurt do have their last trading day on 15.08.2024Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 15.08.2024ISIN NameCA4296442060 HIGH... ► Artikel lesen | |
BZAM | 0,015 | 0,00 % | XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 20.09.2024 | The following instruments on Boerse Frankfurt do have their last trading day on 20.09.2024Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 20.09.2024ISIN NameAU000000SCL8 SCHROLE... ► Artikel lesen | |
TONIX PHARMACEUTICALS | 11,480 | 0,00 % | Tonix Pharmaceuticals Holding Corp.: Tonix Pharmaceuticals Recently Announced Preliminary Full Year 2024 Operating Results and Year-End Cash | Company had $98.8 million in cash as of December 31, 2024; existing cash expected to fund planned operations into the first quarter of 2026 Company is debt-free after repaying mortgage on facilities... ► Artikel lesen | |
CSPC PHARMA | 0,578 | +2,84 % | CSPC Pharmaceutical Group-Aktie mit leichten Kursgewinnen (0,575 €) | Im Plus liegt zur Stunde die Aktie der CSPC Pharmaceutical Group . Der jüngste Kurs betrug 0,57 Euro. Das Wertpapier der CSPC Pharmaceutical Group verzeichnet derzeit eine Verteuerung von 3,32 Prozent.... ► Artikel lesen | |
OPKO HEALTH | 1,579 | -0,19 % | OPKO Health, Inc.: ModeX Therapeutics Secures $35 Million BARDA Supplement to Develop COVID Multispecific Antibodies and $16 Million to Initiate Influenza Program | Brings total awards from BARDA to $110 million for development of broad SARS-CoV-2 and Influenza multispecifics, with potential funding of up to $205 million if all options are executedDevelopment... ► Artikel lesen | |
PSYCHED WELLNESS | 0,009 | 0,00 % | Psyched Wellness Ltd.: Psyched Wellness Announces Appointment of New Director and Resignation of a Director | Toronto, Ontario--(Newsfile Corp. - November 25, 2024) - Psyched Wellness Ltd. (CSE: PSYC) (OTCQB: PSYCF) (FSE: 5U9) (the "Company" or "Psyched Wellness"), a life sciences company focused on the production... ► Artikel lesen | |
SELLAS LIFE SCIENCES | 1,270 | +4,96 % | SELLAS Life Sciences Group, Inc.: SELLAS Life Sciences Announces Positive Outcome of Interim Analysis for its Pivotal Phase 3 REGAL Trial of GPS in Acute Myeloid Leukemia | - REGAL Successfully Passes Event-Driven (60 Deaths) Interim Analysis for Efficacy, Futility, and Safety: The Independent Data Monitoring Committee (IDMC) Recommended Continuation of the Clinical... ► Artikel lesen |